Capricor Therapeutics Inc (NASDAQ:CAPR)
| 5.66 BATS BZX Real-Time Price As of 12:39pm ET |  +0.09 / +1.62%Today’s Change | 3.30 Today|||52-Week Range 8.22 | +46.63% Year-to-Date |
Latest CAPR News | Press Releases
No recent news for Capricor Therapeutics Inc.
Today’s Trading
| Previous close | 5.50 |
| Today’s open | 5.58 |
| Day’s range | 5.51 - 5.67 |
| Volume | 1,591 |
| Average volume (3 months) | 118,010 |
| Market cap | $141.8M |
Data as of 1:01pm ET, 09/25/2023
Growth & Valuation
| Earnings growth (last year) | -36.29% |
| Earnings growth (this year) | +25.85% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +941.85% |
| P/E ratio | NM |
| Price/Sales | 37.14 |
| Price/Book | 11.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Immunovia AB (publ) | 0.00 | 0.00% |
| TRVITrevi Therapeutics I... | +0.05 | +2.31% |
| KPTIKaryopharm Therapeut... | +0.12 | +9.54% |
| ---- |
Data as of 1:13pm ET, 09/26/2023
Financials
| Next reporting date | November 9, 2023 |
| EPS forecast (this quarter) | -$0.32 |
| Annual revenue (last year) | $2.6M |
| Annual profit (last year) | -$29.0M |
| Net profit margin | -1,137.37% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
